Pnc Financial Services Group, Inc. Mersana Therapeutics, Inc. Transaction History
Pnc Financial Services Group, Inc.
- $190 Billion
- Q1 2025
A detailed history of Pnc Financial Services Group, Inc. transactions in Mersana Therapeutics, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 3,537 shares of MRSN stock, worth $1,344. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,537
Previous 200
1668.5%
Holding current value
$1,344
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding MRSN
# of Institutions
116Shares Held
101MCall Options Held
16.3KPut Options Held
13K-
Nextech Invest, Ltd. Zurich, V812.1MShares$4.59 Million0.97% of portfolio
-
Nextech Invest Ag12.1MShares$4.59 Million3.22% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA8.66MShares$3.29 Million0.99% of portfolio
-
Black Rock Inc. New York, NY8.38MShares$3.19 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.38MShares$3.18 Million0.0% of portfolio
About Mersana Therapeutics, Inc.
- Ticker MRSN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,169,296
- Market Cap $36.9M
- Description
- Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...